TrialBMC infectious diseases2018

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).

Thijs Ten Doesschate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.